Chapter 18. Recent Advances in the Treatment of Inflammatory Bowel Disease
- 1 January 1989
- book chapter
- Published by Elsevier
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Hemmung der intestinalen Leukotrien-Bildung als mögliches Wirkprinzip von Sulfasalazin, 5-Aminosalizylsäure und 4-AminosalizylsäureJournal of Molecular Medicine, 1988
- Leukotriene B4 and inflammatory diseaseInflammation Research, 1988
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Possible mode of action of 5-aminosalicylic acidDigestive Diseases and Sciences, 1987
- Sulfasalazine and Related New DrugsThe Journal of Clinical Pharmacology, 1987
- Experimental models for ulcerative colitisDigestive Diseases and Sciences, 1985
- Animal models of inflammatory bowel disease?An overviewDigestive Diseases and Sciences, 1985
- Prostanoids cytoprotection for maintaining remission in ulcerative colitis failure of 15(R), 15-methylprostaglandin E2Digestive Diseases and Sciences, 1983
- Studies of two novel sulfasalazine analogs, ipsalazide and balsalazideDigestive Diseases and Sciences, 1983
- Actions of anticolitic drugs on a guinea-pig model of immune colitisInflammation Research, 1982